Al-Zuaidy Mizher Hezam, Mumtaz Muhammad Waseem, Hamid Azizah Abdul, Ismail Amin, Mohamed Suhaila, Razis Ahmad Faizal Abdul
Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
Ministry of Iraqi Trade, State Company for Grain Processing, Baghdad, Iraq.
BMC Complement Altern Med. 2017 Jul 10;17(1):359. doi: 10.1186/s12906-017-1849-2.
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by continuous hyperglycemia associated with insulin resistance and /or reduced insulin secretion. There is an emerging trend regarding the use of medicinal plants for the treatment of diabetes mellitus. Melicope lunu-ankenda (ML) is one of the Melicope species belonging to the family Rutaceae. In traditional medicines, its leaves and flowers are known to exhibit prodigious health benefits. The present study aimed at investigating anti-diabetic effect of Melicope lunu-ankenda (ML) leaves extract.
In this study, anti-diabetic effect of ML extract is investigated in vivo to evaluate the biochemical changes, potential serum biomarkers and alterations in metabolic pathways pertaining to the treatment of HFD/STZ induced diabetic rats with ML extract using H NMR based metabolomics approach. Type 2 diabetic rats were treated with different doses (200 and 400 mg/kg BW) of Melicope lunu-ankenda leaf extract for 8 weeks, and serum samples were examined for clinical biochemistry. The metabolomics study of serum was also carried out using H NMR spectroscopy in combination with multivariate data analysis to explore differentiating serum metabolites and altered metabolic pathways.
The ML leaf extract (400 mg/kg BW) treatment significantly increased insulin level and insulin sensitivity of obese diabetic rats, with concomitant decrease in glucose level and insulin resistance. Significant reduction in total triglyceride, cholesterol and low density lipoprotein was also observed after treatment. Interestingly, there was a significant increase in high density lipoprotein of the treated rats. A decrease in renal injury markers and activities of liver enzymes was also observed. Moreover, metabolomics studies clearly demonstrated that, ML extract significantly ameliorated the disturbance in glucose metabolism, tricarboxylic acid cycle, lipid metabolism, and amino acid metabolism.
ML leaf extract exhibits potent antidiabetic properties, hence could be a useful and affordable alternative option for the management of T2DM.
2型糖尿病(T2DM)是一种代谢紊乱疾病,其特征为持续高血糖,并伴有胰岛素抵抗和/或胰岛素分泌减少。使用药用植物治疗糖尿病的趋势正在兴起。轮叶蜜茱萸(ML)是芸香科蜜茱萸属的一种植物。在传统医学中,其叶和花具有显著的健康益处。本研究旨在探讨轮叶蜜茱萸(ML)叶提取物的抗糖尿病作用。
在本研究中,采用基于氢核磁共振的代谢组学方法,在体内研究ML提取物的抗糖尿病作用,以评估用ML提取物治疗高脂饮食/链脲佐菌素诱导的糖尿病大鼠后,其生化变化、潜在血清生物标志物以及代谢途径的改变。给2型糖尿病大鼠用不同剂量(200和400mg/kg体重)的轮叶蜜茱萸叶提取物治疗8周,并检测血清样本的临床生化指标。还采用氢核磁共振光谱结合多变量数据分析对血清进行代谢组学研究,以探索血清代谢物的差异和代谢途径的改变。
ML叶提取物(400mg/kg体重)治疗显著提高了肥胖糖尿病大鼠的胰岛素水平和胰岛素敏感性,同时降低了血糖水平和胰岛素抵抗。治疗后还观察到总甘油三酯、胆固醇和低密度脂蛋白显著降低。有趣的是,治疗大鼠的高密度脂蛋白显著增加。还观察到肾损伤标志物和肝酶活性降低。此外,代谢组学研究清楚地表明,ML提取物显著改善了葡萄糖代谢、三羧酸循环、脂质代谢和氨基酸代谢的紊乱。
ML叶提取物具有强大的抗糖尿病特性,因此可能是管理T2DM的一种有用且经济实惠的替代选择。